SHZ · Financial Statements

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) Financial Statements

$11.16 SHZ: 002020.SZ Market Cap $9.98B

Full income statement, balance sheet, and cash flow statement for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio2.68
EV / EBITDA7.42
FCF Yield—
Quick Ratio1.95
Interest Coverage—
Return 1Y-36.69%
Return 3Y-4.90%
Return 5Y61.26%

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) financials — frequently asked questions

What is 002020.SZ EV/EBITDA?

Zhejiang Jingxin Pharmaceutical Co., Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 7.42.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002020.SZ Overview 002020.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.